Results 41 to 50 of about 1,731,614 (343)
Coagulation and anticoagulation in idiopathic pulmonary fibrosis [PDF]
, 2015 Idiopathic pulmonary fibrosis (IPF) is an incurable, progressive interstitial lung disease with a prognosis that is worse than that of many cancers. Epidemiological studies have demonstrated a link between IPF and thrombotic vascular events.
Crooks, Michael G., Hart, Simon P.
core +3 more sources
Informal caregivers experience of supplemental oxygen in pulmonary fibrosis
Health and Quality of Life Outcomes, 2017 Background Patients prescribed supplemental oxygen (O2) therapy face challenges as they adjust to being constantly “tethered” to an oxygen delivery device.
Bridget A. Graney +8 more
doaj +1 more source
PLoS ONE, 2021 The characteristics and evolution of pulmonary fibrosis in patients with coronavirus disease 2019 (COVID-19) have not been adequately studied. AI-assisted chest high-resolution computed tomography (HRCT) was used to investigate the proportion of COVID-19
Jia-Ni Zou +9 more
semanticscholar +1 more source
Cough suppression and HRQoL in adult people with cystic fibrosis: an unexplored correlation
Health and Quality of Life Outcomes, 2022 Background Cough suppression assessed by embarrassment about coughing has been shown in adolescents with cystic fibrosis (CF) and negatively affects health-related quality of life (HRQoL) and clinical indicators of disease severity in adolescent females.
Ute Niehammer +7 more
doaj +1 more source
American Journal of Respiratory and Critical Care Medicine, 2019 Rationale: The contributions of diverse cell populations in the human lung to pulmonary fibrosis pathogenesis are poorly understood. Single-cell RNA sequencing can reveal changes within individual cell populations during pulmonary fibrosis that are ...
P. Reyfman +48 more
semanticscholar +1 more source
Respiratory Research, 2021 Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive disorder with an estimated median survival time of 3–5 years after diagnosis. This condition occurs primarily in elderly subjects, and epidemiological studies suggest that the main risk ...
F. Luppi +4 more
semanticscholar +1 more source
Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis [PDF]
, 2015 The aim of this study was to examine the relationship between pulmonary exacerbations and physical activity (PA) in adults with cystic fibrosis (CF)
Banya, Winston +7 more
core +2 more sources
Medicines, 2021 Current FDA-approved antifibrotic treatments for Idiopathic Pulmonary Fibrosis slow down disease progression but have little impact on symptoms or quality of life in patients.
Neha Shah
doaj +1 more source
Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis
International Journal of Molecular Sciences, 2020 Alveolar epithelial type II cells (AT2) are a heterogeneous population that have critical secretory and regenerative roles in the alveolus to maintain lung homeostasis.
T. Parimon +4 more
semanticscholar +1 more source
Centrilobular emphysema combined with pulmonary fibrosis results in improved survival: a response [PDF]
, 2011 Better survival in combined pulmonary fibrosis and emphysema than in lone pulmonary fibrosis: bias or reality? A response to Centrilobular emphysema combined with pulmonary fibrosis results in improved survival by Todd et al., Fibrogenesis & Tissue ...
Athol U Wells +8 more
core +2 more sources